Maven Securities LTD Makes New $1.67 Million Investment in Sotera Health (NASDAQ:SHC)

Maven Securities LTD acquired a new position in Sotera Health (NASDAQ:SHC - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 100,000 shares of the company's stock, valued at approximately $1,670,000.

Other institutional investors have also added to or reduced their stakes in the company. True Wealth Design LLC purchased a new position in shares of Sotera Health during the third quarter worth approximately $32,000. CWM LLC increased its position in shares of Sotera Health by 86.1% during the second quarter. CWM LLC now owns 2,146 shares of the company's stock worth $25,000 after acquiring an additional 993 shares during the period. GAMMA Investing LLC increased its position in shares of Sotera Health by 125.0% during the third quarter. GAMMA Investing LLC now owns 2,988 shares of the company's stock worth $50,000 after acquiring an additional 1,660 shares during the period. Capital Performance Advisors LLP purchased a new position in shares of Sotera Health during the third quarter worth approximately $91,000. Finally, Point72 DIFC Ltd increased its position in shares of Sotera Health by 556.6% during the second quarter. Point72 DIFC Ltd now owns 6,540 shares of the company's stock worth $78,000 after acquiring an additional 5,544 shares during the period. Institutional investors own 91.03% of the company's stock.

Analysts Set New Price Targets

A number of brokerages have recently commented on SHC. Citigroup raised their target price on shares of Sotera Health from $18.00 to $20.00 and gave the stock a "buy" rating in a research report on Wednesday, November 6th. Barclays lifted their price objective on shares of Sotera Health from $14.00 to $17.00 and gave the company an "overweight" rating in a report on Tuesday, August 6th. Finally, Royal Bank of Canada reissued an "outperform" rating and set a $17.00 price objective on shares of Sotera Health in a report on Thursday, November 21st. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, Sotera Health presently has an average rating of "Moderate Buy" and a consensus price target of $16.50.

Insider Transactions at Sotera Health

In related news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the business's stock in a transaction on Friday, September 6th. The shares were sold at an average price of $15.03, for a total transaction of $150,300,000.00. Following the completion of the transaction, the director now directly owns 49,215,301 shares in the company, valued at $739,705,974.03. The trade was a 16.89 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 55.12% of the company's stock.

Sotera Health Stock Up 3.5 %

NASDAQ SHC traded up $0.45 on Wednesday, hitting $13.28. The stock had a trading volume of 2,511,128 shares, compared to its average volume of 1,347,193. The business's fifty day moving average price is $15.10 and its 200 day moving average price is $14.07. The company has a debt-to-equity ratio of 4.91, a current ratio of 2.88 and a quick ratio of 2.61. Sotera Health has a 52-week low of $10.71 and a 52-week high of $17.44. The stock has a market cap of $3.76 billion, a price-to-earnings ratio of 51.32 and a beta of 1.96.

Sotera Health (NASDAQ:SHC - Get Free Report) last released its quarterly earnings results on Tuesday, November 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.01). Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. The firm had revenue of $285.47 million during the quarter, compared to analysts' expectations of $278.64 million. During the same period in the prior year, the firm posted $0.18 earnings per share. Sotera Health's revenue for the quarter was up 8.5% compared to the same quarter last year. Equities research analysts anticipate that Sotera Health will post 0.61 earnings per share for the current year.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.